Healthways (NASDAQ: HWAY) 24% LOWER; announced that the Company is revising its financial guidance for 2015. The Company now expects revenue for 2015 in a range of $770 million to $785 million compared to a previous range of $800 million to $825 million and revenues of $742 million for 2014. The Company expects the resulting impact on EBITDA from this revenue reduction to be approximately $20 million at the mid-point of the revised revenue guidance range. EBITDA will be further reduced, as previously announced, by approximately $5 million from compensation-related expenses associated with its CEO transition. Consequently the Company
previous post
next post